688578 Stock Overview
Shanghai Allist Pharmaceuticals Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688578 from our risk checks.
Shanghai Allist Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥57.87 |
| 52 Week High | CN¥68.87 |
| 52 Week Low | CN¥32.25 |
| Beta | 0.58 |
| 11 Month Change | 5.53% |
| 3 Month Change | 19.94% |
| 1 Year Change | 57.04% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 133.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688578 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.7% | -1.4% | -2.0% |
| 1Y | 57.0% | -6.0% | 4.6% |
Return vs Industry: 688578 exceeded the CN Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: 688578 exceeded the CN Market which returned 2% over the past year.
Price Volatility
| 688578 volatility | |
|---|---|
| 688578 Average Weekly Movement | 10.1% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688578 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688578's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,044 | Jinhao Du | www.allist.com.cn |
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.
Shanghai Allist Pharmaceuticals Co., Ltd. Fundamentals Summary
| 688578 fundamental statistics | |
|---|---|
| Market cap | CN¥26.04b |
| Earnings (TTM) | CN¥1.30b |
| Revenue (TTM) | CN¥3.20b |
20.1x
P/E Ratio8.1x
P/S RatioIs 688578 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688578 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.20b |
| Cost of Revenue | CN¥164.74m |
| Gross Profit | CN¥3.04b |
| Other Expenses | CN¥1.74b |
| Earnings | CN¥1.30b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.88 |
| Gross Margin | 94.86% |
| Net Profit Margin | 40.47% |
| Debt/Equity Ratio | 0% |
How did 688578 perform over the long term?
See historical performance and comparison